Track record · closed signal

Premier Inc. (PINC) — closed signal from July 3, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on October 1, 2025 — +27.3% at the close.

Predicted vs. what happened

PINC price · publication thesis → realized outcomesplit-adjusted
$21.83 Published $24.48 Target $27.80 Window close $28.79 Peak
$20.67 – $22.14Entry zone — fair-value band
$21.83Published — price the day we called it
$24.48Target — the price the thesis aimed for
$28.79Peak — highest point inside the window, not a realized return
$27.80Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 43 days.

At window close
+27.3%
realized, from the publication price to the last close inside the window
Peak gain
+31.9%
peak, from the publication price — not a realized return
S&P 500, same window
+7.2%
SPY over the identical days, dividend-adjusted
Window close
$27.80
last close inside the window, ended October 1, 2025
Peak price
$28.79
peak on September 8, 2025 — not a realized return
Days to target
43

The thesis — published July 3, 2025

Predicted growth
+13%
over the measurement window
Target price
$24.48
the price the thesis aimed for
Entry zone
$20.67 – $22.14
the fair-value band we waited for
Price at publication
$21.83
published July 3, 2025
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

After climbing earlier this year, the share price has now given back about two-thirds of those gains, which often sets the stage for a quick rebound. The recent purchase of IllumiCare broadens Premier’s software tools for hospitals, and sales last quarter beat forecasts by 7.4 percent. Because over 8 percent of shares are being bet against, any good news could push the price up 12-15 percent toward $23.80 as the deal gets rolled out.

Primary drivers

  • Price looks oversold; similar past situations often led to 10-15% rises within two months.
  • Buying IllumiCare could add about $400 million in potential customers and raise software sales share.
  • Last quarter’s sales beat estimates by 7.4%, easing worries that growth was stalling.
  • More than 8% of shares are shorted, so a positive turn could force quick buying and lift the price.

How it played out

PINC: target reached in 43 days

Lyra published PINC on 2025-07-03 at $21.83. The thesis expected 13% growth and pointed to an oversold setup after the stock gave back about two-thirds of earlier gains. It also pointed to the IllumiCare purchase, last quarter's sales beat of 7.4%, and more than 8% of shares being shorted.

Inside the window from 2025-07-03 to 2025-10-01, the stock reached the target in 43 days. It peaked at $28.79 on 2025-09-08, above the $24.48 target, with a peak gain of 31.9%. It ended at $27.8. The thesis played out.

What happened during the window

On 2025-09-22, Premier agreed to be acquired by Patient Square Capital in a deal valued at about $2.6 billion. The reported cash price was $28.25 per share.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All PINC signals